South Korea
· Delayed Price · Currency is KRW IL Science Statistics
Total Valuation
IL Science has a market cap or net worth of KRW 87.18 billion. The enterprise value is 166.05 billion.
| Market Cap | 87.18B |
| Enterprise Value | 166.05B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IL Science has 26.70 million shares outstanding. The number of shares has increased by 10.29% in one year.
| Shares Outstanding | 26.70M |
| Shares Change (YoY) | +10.29% |
| Shares Change (QoQ) | +7.09% |
| Owned by Insiders (%) | 27.73% |
| Owned by Institutions (%) | n/a |
| Float | 19.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.28 |
| PB Ratio | 6.42 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -18.64 |
| EV / Sales | 2.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.43 |
Financial Position
The company has a current ratio of 0.47, with a Debt / Equity ratio of 3.02.
| Current Ratio | 0.47 |
| Quick Ratio | 0.32 |
| Debt / Equity | 3.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.04 |
| Interest Coverage | -1.72 |
Financial Efficiency
Return on equity (ROE) is -32.19% and return on invested capital (ROIC) is -8.56%.
| Return on Equity (ROE) | -32.19% |
| Return on Assets (ROA) | -6.66% |
| Return on Capital (ROIC) | -8.56% |
| Revenue Per Employee | 1.33B |
| Profits Per Employee | -178.13M |
| Employee Count | 50 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 7.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.51% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +14.51% |
| 50-Day Moving Average | 3,154.90 |
| 200-Day Moving Average | 3,058.95 |
| Relative Strength Index (RSI) | 51.55 |
| Average Volume (20 Days) | 215,696 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IL Science had revenue of KRW 66.69 billion and -8.91 billion in losses. Loss per share was -364.76.
| Revenue | 66.69B |
| Gross Profit | 13.75B |
| Operating Income | -10.59B |
| Pretax Income | -8.02B |
| Net Income | -8.91B |
| EBITDA | -6.39B |
| EBIT | -10.59B |
| Loss Per Share | -364.76 |
Balance Sheet
The company has 6.94 billion in cash and 74.67 billion in debt, giving a net cash position of -67.72 billion or -2,536.24 per share.
| Cash & Cash Equivalents | 6.94B |
| Total Debt | 74.67B |
| Net Cash | -67.72B |
| Net Cash Per Share | -2,536.24 |
| Equity (Book Value) | 24.74B |
| Book Value Per Share | 508.88 |
| Working Capital | -48.26B |
Cash Flow
In the last 12 months, operating cash flow was -7.02 billion and capital expenditures -5.34 billion, giving a free cash flow of -12.37 billion.
| Operating Cash Flow | -7.02B |
| Capital Expenditures | -5.34B |
| Free Cash Flow | -12.37B |
| FCF Per Share | -463.12 |
Margins
Gross margin is 20.62%, with operating and profit margins of -15.88% and -13.35%.
| Gross Margin | 20.62% |
| Operating Margin | -15.88% |
| Pretax Margin | -12.02% |
| Profit Margin | -13.35% |
| EBITDA Margin | -9.58% |
| EBIT Margin | -15.88% |
| FCF Margin | -18.54% |
Dividends & Yields
IL Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.29% |
| Shareholder Yield | -10.29% |
| Earnings Yield | -11.17% |
| FCF Yield | -14.18% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IL Science has an Altman Z-Score of 0.06. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.06 |
| Piotroski F-Score | n/a |